跳至主要内容
临床试验/CTRI/2020/03/023876
CTRI/2020/03/023876进行中(未招募)4 期

An open label randomised clinical trial to determine the efficacy of Rohitakadi Churna along with Triphaladi Granules in the management of Madhumeha with special reference to Diabetes Mellitus (type 2)

All India Institute of Ayurveda0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
进行中(未招募)
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of either gender in the age group of 25 to 65 years
  • 2. Patients with classical signs and symptoms of Prameh or Madhumeha viz Prabhuta Mutrata Avila Mutrata Pipasadhikya Alasya Utsahahani Kshudhadhikya Pindikodveshthana Karapadatala Suptata Daurbalya Nidradhikya and Purishabadhdhata.
  • 3. Inclusion criteria based on blood investigations
  • Fasting blood sugar FBS less than 140 mg per dl up to 200 mg per dl and
  • Patients with random blood sugar level RBS more than 200 mg per dl upto 350 or
  • Postprandial blood sugar PPBS more than 200 mg per dl up to 350 mg per dl and
  • Glycosylated haemoglobin more than 6.5 percent upto 10 percent
  • 4. Newly or early diagnosed cases to be included as per following criteria
  • Patients who are not taking any conventional medicine for more than two months whose sugar levels are raised and fall within the inclusive criteria mentioned above and are willing to take Ayurvedic treatment
  • Patient accidently diagnosed in routine checkup or when appeared with other complaints in the hospital.
  • Early diagnosed diabetic patients less than 2yr of diabetic history and not taking any pharmacological drugs since last two months.
  • 5. Frequency of urination 7 to 10 times per 24 hours or quantity equal or more than 2500ml per 24 hours
  • 6. Presence of urine sugar

排除标准

  • 1. Patients with acute or chronic liver disease with elevated liver enzymes.
  • 2. Patients with history of alcohol abuse.
  • 3. Patients having insulin dependent DM type 1 and receiving insulin
  • 4. Chronic complications like microvascular and macrovascular derangements.
  • 5. Hyper or hypothyroidism
  • 6. Patients reporting to be hypersensitive to any of the proposed trial drugs.
  • 7. Patients on vitamin B supplementation, NSAIDs.
  • 8. Pregnant women or lactating mothers
  • 9. Participation in other clinical studies in past 12 weeks.
  • 10. Takes psychotropic medications that raise blood glucose e.g. atypical antipsychotics

研究者

相似试验